Back

Prasugrel-, ticagrelor-, or clopidogrel-based dual antiplatelet therapy after acute coronary syndrome: a frequentist network meta-analysis

28 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Beyond myocardial ischaemia: different aspects of pharmacotherapy and revascularisation Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Mrinal Murali Krishna

St. Gregorios Medical Mission Multi-Speciality Hospital, Kerala (India)

6 More presentations in this session

Presentation thumbnail
Thiamine as an emerging biomarker for postoperative arrhythmias after coronary artery bypass grafting surgery.
Assistant Professor L. Rufino Garcia (Botucatu, BR)
Abstract Slides Video
Presentation thumbnail
Your Heart Speaks Survey Programme – the characteristics associated with an early versus late diagnosis in ANOCA patients.
Professor J. Beltrame (Adelaide, AU)
Abstract Slides Video
Presentation thumbnail
Saving myocardium: the protective role of filter devices during culprit overexpansion in STEMI
Doctor M. Kanegawa (Hiroshima, JP)
Abstract Slides Video
Presentation thumbnail
Beyond CYP2C19: clinical phenotype drives events and P2Y12 escalation in a real-world Andean population
Doctor M. Tinoco Lara (Quito, EC)
Abstract Slides Video
Presentation thumbnail
Drug coated balloon versus drug eluting stent angioplasty in patients presenting with STEMI: a systematic review and meta-analysis
Doctor P. Iliakis (Athens, GR) Doctor N. Pyrpyris (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Beyond myocardial ischaemia: different aspects of pharmacotherapy and revascularisation

The Event

Event poster

ESC Congress 2026

28 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Optimal antiplatelet strategies after complex percutaneous coronary intervention in newer drug-eluting stent era: a bayesian network meta-analysis of randomized-controlled trials
29 August 2026
thumbnail
Congress Presentation
Choosing the most effective and safest P2Y12 Inhibitor for use in >70-year-old acute coronary syndrome patients: a network meta-analysis
30 August 2024
thumbnail
Congress Presentation
A meta-analysis on the efficacy of ticagrelor monotherapy after 3 months of dual antiplatelet therapy vs ticagrelor plus aspirin dual therapy on patients with ACS who underwent PCI
27 August 2023
thumbnail
Congress Presentation
Ticagrelor-based dual antithrombotic therapy in anticoagulated patients undergoing PCI: a pooled analysis of two multicenter registries
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources